Detalhe da pesquisa
1.
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy.
J Hepatol
; 71(1): 45-51, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853642
2.
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.
J Antimicrob Chemother
; 73(9): 2435-2443, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982683
3.
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
Clin Infect Dis
; 65(6): 1012-1019, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28903510
4.
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Hepatology
; 61(5): 1503-11, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545020
5.
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.
BMC Infect Dis
; 15: 557, 2015 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643257
6.
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Clin Infect Dis
; 57(10): 1401-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23946224
7.
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Hepatology
; 56(1): 228-38, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22278746
8.
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice.
HIV Clin Trials
; 19(1): 23-30, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29447085
9.
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.
J Infect
; 71(5): 571-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26212868
10.
Leishmaniasis visceral con manifestaciones en lengua
O.R.L.-DIPS
; 30(4): 213-217, oct. 2003. ilus
Artigo
em Es
| IBECS (Espanha) | ID: ibc-32100